China diagnostic reagent_industry_report_2010
Upcoming SlideShare
Loading in...5
×
 

Like this? Share it with your network

Share

China diagnostic reagent_industry_report_2010

on

  • 374 views

 

Statistics

Views

Total Views
374
Views on SlideShare
374
Embed Views
0

Actions

Likes
0
Downloads
1
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

China diagnostic reagent_industry_report_2010 Document Transcript

  • 1. China Diagnostic Reagent Industry Report,2012-2014Phone: +44 20 8123 2220Fax: +44 207 900 3970office@marketpublishers.comhttp://marketpublishers.com
  • 2. Phone: +44 20 8123 2220 http://marketpublishers.comChina Diagnostic Reagent Industry Report, 2012-2014 Date: January 4, 2013 Pages: 86 Price: US$ 2,100.00 ID: C2A95AF875BENChina’s diagnostic reagent industry has formed a certain market scale and basis, and is marching from theintroduction stage to the growth stage. With the continuous growth in China’s medical care investment andper capita health care spending, the China’s diagnostic reagent market has a promising prospect.In vitro diagnostic reagents account for more than 90.0% of the output of China’s diagnostic reagentindustry. In 2011, the market scale of in vitro diagnostic reagents reached about RMB 11.4 billion in China,the industry will maintain a growth rate of 15%-20% in the future, and the market scale will hit RMB 20.8billion in 2015.At present, there are only a few integrated in vitro diagnostic reagent enterprises with strong strength inChina’s diagnostic reagent market, including KHB and Fosun Pharma; other enterprises such as Da AnGene, BioSino, Leadman and Livzon have competitive advantages in specific fields such as biochemicaldiagnosis, immunodiagnosis, and molecular diagnosis. Meanwhile, China’s in vitro diagnostic reagentindustry concentration is low. Among 300-400 enterprises, there are only about 20 enterprises with annualsales of more than RMB 100 million. The enterprises are generally small and have a few product varieties.In 2011, KHB, Da An Gene, BioSino, Leadman only occupied 3.8%, 2.3%, 1.9%, 1.6% of the marketrespectively.As a high-tech industry, the profitability of the overall Chinese diagnostic reagent industry is high. In 2011,among major Chinese diagnostic reagent enterprises, KHB, Da An Gene, BioSino, Kinghawk, Livzon,Leadman all achieved a gross margin of more than 50%; Fosun Pharma reached a gross margin of 40.4%,since diagnostic reagent and instrument business accounts for a lower proportion of its revenue. With theimprovement of industry concentration, it’s expected that the advantageous enterprises with strongcapability of technological innovation and large production scale will obtain higher market share andprofitability.China Diagnostic Reagent Industry Report, 2012-2014 mainly includes the following contents: Market scale, market structure, import and export, competitive landscape, profitability, entry barriers of China’s diagnostic reagent industry; Regulatory system and policy, industry policy, industrial chain, upstream and downstream of China’s diagnostic reagent industry; Development forecast of China’s diagnostic reagent industry, including the forecast of market scale, major market segments, industry competition, and enterprise development trends; Production, operation, investment, M&A, diagnostic reagent business and development prospect of 15 Chinese diagnostic reagent enterprises.Table of Content1. OVERVIEW OF DIAGNOSTIC REAGENT INDUSTRY1.1 Definition1.2 ClassificationChina Diagnostic Reagent Industry Report, 2012-2014 2
  • 3. Phone: +44 20 8123 2220 http://marketpublishers.com2. CHINA DIAGNOSTIC REAGENT INDUSTRY2.1 Overview2.2 Market Structure2.3 Import and Export 2.3.1 Import 2.3.2 Export2.4 Competitive Landscape 2.4.1 Biochemical Diagnostic Reagents 2.4.2 Immune Diagnostic Reagents 2.4.3 Molecular Diagnostic Reagents 2.4.4 Integrated In Vitro Diagnostic Reagents2.5 Profitability2.6 Entry Barriers 2.6.1 Technical Barriers 2.6.2 Quality and Brand Barriers 2.6.3 Marketing Channel Barriers 2.6.4 Market Access Barriers3. DEVELOPMENT ENVIRONMENT OF CHINA DIAGNOSTIC REAGENT INDUSTRY3.1 Policy Environment 3.1.1 Regulatory Policy 3.1.2 Industry Policy3.2 Upstream and Downstream Industries 3.2.1 Industrial Chain 3.2.2 Upstream 3.2.3 Downstream4. DEVELOPMENT FORECAST OF CHINA DIAGNOSTIC REAGENT INDUSTRY4.1 Overall Forecast 4.1.1 Market Demand Drivers 4.1.2 Market Scale Forecast4.2 Development Trends of Diagnostic Reagent Industry 4.2.1 Biochemical Diagnosis and Immunodiagnosis Will Still Be the Mainstream 4.2.2 Industry Concentration Will Increase 4.2.3 Enterprises with Complete Product Line Integrating Reagents and Instruments will Win5. MAJOR CHINESE DIAGNOSTIC REAGENT ENTERPRISES5.1 Shanghai Kehua Bio-engineering Co., Ltd. (KHB) 5.1.1 Profile 5.1.2 Operation 5.1.3 Revenue Structure 5.1.4 Gross Margin 5.1.5 R & D and Investment 5.1.6 Customers 5.1.7 Diagnostic Reagent Business 5.1.8 Forecast and Prospect5.2 Da An Gene Co., Ltd. 5.2.1 Profile 5.2.2 Operation 5.2.3 Revenue StructureChina Diagnostic Reagent Industry Report, 2012-2014 3
  • 4. Phone: +44 20 8123 2220 http://marketpublishers.com 5.2.4 Gross Margin 5.2.5 R & D and Investment 5.2.6 Diagnostic Reagent Business 5.2.7 Forecast and Prospect5.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 5.3.1 Profile 5.3.2 Operation 5.3.3 Revenue Structure 5.3.4 Gross Margin 5.3.5 R & D and Investment 5.3.6 Diagnostic Reagent Business 5.3.7 Forecast and Prospect5.4 BioSino Bio-technology and Science Inc. 5.4.1 Profile 5.4.2 Operation 5.4.3 Revenue Structure 5.4.4 R & D and Investment 5.4.5 Forecast and Prospect5.5 Beijing Kinghawk Pharmaceutical Co., Ltd. 5.5.1 Profile 5.5.2 Operation 5.5.3 Revenue Structure 5.5.4 Gross Margin 5.5.5 Diagnostic Reagent Business 5.5.6 Forecast and Prospect5.6 Livzon Pharmaceutical Group Inc. 5.6.1 Profile 5.6.2 Operation 5.6.3 Revenue Structure 5.6.4 Gross Margin 5.6.5 Diagnostic Reagent Business 5.6.6 Forecast and Prospect5.7 Beijing Leadman Biochemistry Co., Ltd. 5.7.1 Profile 5.7.2 Operation 5.7.3 Revenue Structure 5.7.4 Gross Margin 5.7.5 R & D and Investment 5.7.6 Customers 5.7.7 Diagnostic Reagent Business 5.7.8 Forecast and Prospect5.8 Acon Biotech (Hangzhou) Co., Ltd. 5.8.1 Profile 5.8.2 Operation 5.8.3 Development5.9 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. 5.9.1 Profile 5.9.2 Operation 5.9.3 Development5.10 Shanghai Rongsheng Biotech Co., Ltd. (Rsbio) 5.10.1 Profile 5.10.2 Operation 5.10.3 Development5.11 Shenzhen PG Biotech Co., Ltd. 5.11.1 ProfileChina Diagnostic Reagent Industry Report, 2012-2014 4
  • 5. Phone: +44 20 8123 2220 http://marketpublishers.com 5.11.2 Operation5.12 Shanghai Upper Bio-Tech Pharma Co., Ltd. 5.12.1 Profile 5.12.2 Operation 5.12.3 Development5.13 Inverness Medical (Shanghai) Co., Ltd. 5.13.1 Profile 5.13.2 Operation5.14 Blue Cross Bio-Medical (Beijing) Co., Ltd. 5.14.1 Profile 5.14.2 Operation 5.14.3 Development5.15 Beijing North Institute of Biological Technology (BNIBT) 5.15.1 Profile 5.15.2 Operation 5.15.3 DevelopmentSELECTED CHARTSShanghai Kehua Bio-engineering Co., Ltd. (KHB)Da An Gene Co., Ltd.Shanghai Fosun Pharmaceutical (Group) Co., Ltd.BioSino Bio-technology and Science Inc.Beijing Kinghawk Pharmaceutical Co., Ltd.Livzon Pharmaceutical Group Inc.Beijing Leadman Biochemistry Co., Ltd.Acon Biotech (Hangzhou) Co., Ltd.Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.Shanghai Rongsheng Biotech Co., Ltd. (Rsbio)Shenzhen PG Biotech Co., Ltd.Shanghai Upper Bio-Tech Pharma Co., Ltd.Inverness Medical (Shanghai) Co., Ltd.Blue Cross Bio-Medical (Beijing) Co., Ltd.Beijing North Institute of Biological Technology (BNIBT)China Diagnostic Reagent Industry Report, 2012-2014 5
  • 6. Phone: +44 20 8123 2220 http://marketpublishers.com I would like to order: Product name: China Diagnostic Reagent Industry Report, 2012-2014 Product link: http://marketpublishers.com/r/C2A95AF875BEN.html Product ID: C2A95AF875BEN Price: US$ 2,100.00 (Single User License / Electronic Delivery) If you want to order Corporate License or Hard Copy, please, contact our Customer Service: office@marketpublishers.com Payment To pay by Credit Card (Visa, MasterCard, American Express, PayPal), please, click BUY NOW button on product page http://marketpublishers.com/r/C2A95AF875BEN.html To pay by Wire Transfer, please, fill in your contact details in the form below: First name: Last name: E-mail: Company: Address: City: Zip/Post Code: Country: Tel: Fax: Your message: * All fields are required Customer Signature _______________________________________ Please, note that by ordering from MarketPublisher.com you are agreeing to our Terms & Conditions at http://marketpublishers.com/docs/terms_conditions.html To place an order via fax simply print this form, fill in the information below and fax the completed form to +44 20 7900 3970Powered by TCPDF (www.tcpdf.org)